ACB Company Profile and Key Details

Wall Street analysts project EPS growth of 44.28% annually over the next five years. The latest quarter delivered EPS of $0.04. The next quarter is forecast at -$0.04. Next year's EPS is expected at $45.35. Aurora Cannabis Inc. earnings surprise history is frequent misses against expectations. The quarter that ended August 05, 2026, missed forecasts by -130.77%. The prior quarter beat by -79.26%. Over the last six quarters, Apple has recorded several small beats. These include -36.36% in June 18, 2025.

Short-term trend indicators are bullishly aligned (SMA20 5.01%, SMA50 -6.88%, SMA200 -18.32%). The stock’s 14-day RSI is 51.21 (neutral), while the ATR of 0.18 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -41.64% below its high and over 18.6% above its low. Average 10-day trading volume of 956.07 thousand shares is below the 3-month average of 1.44 million, indicating normal recent market interest.

Aurora Cannabis Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $3.81. This means the shares are trading near this model’s fair value.

The stock is currently mid-range between its 52-week high and low $2.56 and $6.67. With a market capitalization of about $231.35 million, Aurora Cannabis Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.45). Key stats such as the average daily volume over the past year has been around 1.42 million shares, volume is running light vs its 52-week average. Headquartered in Edmonton, AB, Aurora Cannabis Inc. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Miguel Martin, the company employs approximately 1,028 people and listed since July 15, 2014. Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally.

Aurora Cannabis Inc. (NASDAQ:ACB) shares are flat -1.9% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Aurora Cannabis Inc. trading at a premium to the broader market with a P/E of -2.69. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $6.19, suggesting 65.95% upside. Our AI forecast model points to short-term strength (8.58% over two weeks), a medium-term fall (-49.6% over three months), and a longer-term gain (80.7% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Aurora Cannabis Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 8.58%, with price expected at $4.05 by September 24, 2026, within a range of $3.84 to $4.26 3-Month Outlook: Projected fall of -49.6%, reaching $1.88 by December 09, 2026, with a range of $1.47 to $2.08. 1-Year Outlook: Projected gain of 80.7%, with price at $6.74 by September 10, 2027, within a range of $0.52 to $7.95.

Aurora Cannabis Inc. trades at a P/E ratio of -2.69, slightly below the S&P 500 average, with a price-to-sales ratio of 1.11 and a price-to-book ratio of 0.61 suggesting the stock is closer to book value. The P/FCF stands at -6.31, also below market averages.